12-56229061-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_024068.4(NABP2):​c.484G>A​(p.Gly162Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0000089 ( 0 hom. )

Consequence

NABP2
NM_024068.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.31
Variant links:
Genes affected
NABP2 (HGNC:28412): (nucleic acid binding protein 2) Single-stranded DNA (ssDNA)-binding proteins, such as OBFC2B, are ubiquitous and essential for a variety of DNA metabolic processes, including replication, recombination, and detection and repair of damage (Richard et al., 2008 [PubMed 18449195]).[supplied by OMIM, Jun 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0336034).
BS2
High AC in GnomAdExome4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NABP2NM_024068.4 linkc.484G>A p.Gly162Ser missense_variant Exon 7 of 7 ENST00000267023.9 NP_076973.1 Q9BQ15-1A0A024RB89

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NABP2ENST00000267023.9 linkc.484G>A p.Gly162Ser missense_variant Exon 7 of 7 1 NM_024068.4 ENSP00000267023.4 Q9BQ15-1
NABP2ENST00000380198.6 linkc.484G>A p.Gly162Ser missense_variant Exon 6 of 6 1 ENSP00000369545.2 Q9BQ15-1
NABP2ENST00000341463.5 linkc.484G>A p.Gly162Ser missense_variant Exon 7 of 7 3 ENSP00000368862.3 Q9BQ15-1
NABP2ENST00000399713.6 linkc.*29G>A downstream_gene_variant 5 ENSP00000408616.1 C9JMP5

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152074
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000410
AC:
10
AN:
244012
Hom.:
0
AF XY:
0.0000302
AC XY:
4
AN XY:
132510
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000496
Gnomad SAS exome
AF:
0.0000331
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000890
AC:
13
AN:
1460786
Hom.:
0
Cov.:
34
AF XY:
0.00000551
AC XY:
4
AN XY:
726578
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000540
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
152074
Hom.:
0
Cov.:
30
AF XY:
0.0000269
AC XY:
2
AN XY:
74282
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 17, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.484G>A (p.G162S) alteration is located in exon 7 (coding exon 6) of the NABP2 gene. This alteration results from a G to A substitution at nucleotide position 484, causing the glycine (G) at amino acid position 162 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Benign
0.92
DEOGEN2
Benign
0.013
T;T;T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.67
.;.;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.034
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.14
N;N;N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.060
N;N;N
REVEL
Benign
0.048
Sift
Benign
1.0
T;T;T
Sift4G
Benign
0.46
T;T;T
Polyphen
0.0040
B;B;B
Vest4
0.22
MutPred
0.22
Gain of glycosylation at G162 (P = 3e-04);Gain of glycosylation at G162 (P = 3e-04);Gain of glycosylation at G162 (P = 3e-04);
MVP
0.30
MPC
0.76
ClinPred
0.072
T
GERP RS
4.5
Varity_R
0.022
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs756410440; hg19: chr12-56622845; API